English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

Grode, L., Ganoza, C. A., Brohm, C., Weiner, J. 3., Eisele, B., & Kaufmann, S. H. E. (2013). Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine, 31(9), 1340-1348. doi:10.1016/j.vaccine.2012.12.053.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Grode, Leander1, Author
Ganoza, Christian A.2, Author           
Brohm, Christiane1, Author
Weiner, January 3rd2, Author           
Eisele, Bernd1, Author
Kaufmann, Stefan H. E.2, Author           
Affiliations:
1External Organizations, ou_persistent22              
2Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society, ou_1664146              

Content

show

Details

show
hide
Language(s):
 Dates: 2013-02-18
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1016/j.vaccine.2012.12.053
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Vaccine
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Guildford, Surrey, UK : Elsevier
Pages: - Volume / Issue: 31 (9) Sequence Number: - Start / End Page: 1340 - 1348 Identifier: ISSN: 0264-410X
CoNE: https://pure.mpg.de/cone/journals/resource/954925498091